Blood and Blood Components Market
- 2026 年市場規模
- USD 51.3 Bn
- 2033 年預估規模
- USD 70.8 Bn
- 年複合成長率 CAGR
- 4.7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Blood and Blood Components Market, By Product Type (Whole Blood, Blood Components (Red Blood Cells, White Blood Cells, Platelets, Plasma)), By Application (Anemia, Trauma and Surgery, Cancer Treatment, Bleeding Disorders, Others (Others include rare blood diseases)), By End User (Hospitals, Ambulatory Surgical Centers, Blood and Blood Component Bank, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Blood is a specialized bodily fluid that circulates through the entire body with the help of a network of blood vessels such as arteries, veins, and capillaries. Blood is made up of four major components, which include red blood cells, white blood cells, plasma, and platelets. Red blood cells, also known as erythrocytes or RBC account for the major portion of blood cells. RBC have a specialized red colored pigment called hemoglobin, which is responsible for carrying oxygen rich blood from the lungs to the rest of the body and deoxygenated blood from the body to the lungs. The average life cycle of RBC is 120 days after which they are removed by the spleen. White blood cells, also known as leukocytes are responsible for making the immune system of the body and help fight against microbial infections. Plasma is the liquid component of blood and is a mixture of water, protein, sugar, salts, and fat. Platelets, also known as thrombocytes help in clotting of blood at the site of tissue injury. Whole blood consists of 45% blood cells and 55% plasma.
According to the American Society of Hematology, blood makes up around 7 to 8% of human body weight. Blood and blood components are used for blood transfusion in case of blood loss during a traumatic injury, hemorrhage to maintain blood volume during cancer treatment, and to treat bleeding disorders.
Market Dynamics
The increasing incidence of bleeding disorders and chronic diseases, rising research and development activities for the development of novel technology for the treatment of bleeding disorders, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global blood and blood components market over the forecast period.
For instance, according to the statistics provided by the World Federation of Hemophilia (WFH) in 2018, over 400,000 people suffered from hemophilia of which around 173,000 people were diagnosed with hemophilia A or B in 2017, across the globe.
Key features of the study
• This report provides in-depth analysis of the global blood and blood components market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global blood and blood components market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Becton, Dickinson & Co., Kidde-Fenwal Inc., Bio-Rad Laboratories, Inc., Cerus Corporation, Immucor, Beckman Coulter, Inc., bioMérieux SA, Octapharma AG, Abbott, CSL Behring LLC, MacoPharma, Shanghai RAAS, China Biologic Products Holdings, Inc., Takeda Pharmaceutical Company Limited, Grifols S.A., Bharat Serums and Vaccines Ltd., and Terumo BCT Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global blood and blood components market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood and blood components market
Market Segmentation
• By Product Type (Revenue, USD Bn, 2021-2033)
o Whole Blood
o Blood Components
o Red Blood Cells
o White Blood Cells
o Platelet
o Plasma
• By Application (Revenue, USD Bn, 2021-2033)
o Anemia
o Trauma and Surgery
o Cancer Treatment
o Bleeding Disorders
o Others (Others include rare blood diseases)
• By End User (Revenue, USD Bn, 2021-2033)
o Hospitals
o Ambulatory Surgical Centers
o Blood and Blood Component Bank
o Others
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Becton, Dickinson & Co.
o Kidde-Fenwal Inc.
o Bio-Rad Laboratories, Inc.
o Cerus Corporation
o Immucor
o Beckman Coulter, Inc.
o bioMerieux SA
o Octapharma AG
o Abbott
o CSL Behring LLC
o MacoPharma
o Shanghai RAAS
o China Biologic Products Holdings, Inc.
o Takeda Pharmaceutical Company Limited
o Grifols S.A.
o Bharat Serums and Vaccines Ltd.
o Terumo BCT Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Blood and Blood Components Market, By Product Type, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Whole Blood
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Blood Components
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Red Blood Cells
o White Blood Cells
o Platelet
o Plasma
5. Global Blood and Blood Components Market, By Application, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Anemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Trauma and Surgery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Cancer Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Bleeding Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Others (Others include rare blood diseases)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
6. Global Blood and Blood Components Market, By End User, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Blood and Blood Component Bank
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
7. Global Blood and Blood Components Market, By Region, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Becton, Dickinson & Co.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Kidde-Fenwal Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Bio-Rad Laboratories, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cerus Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Immucor
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Beckman Coulter, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
bioMerieux SA
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Octapharma AG
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Abbott, CSL Behring LLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
MacoPharma
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Shanghai RAAS
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
China Biologic Products Holdings, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Takeda Pharmaceutical Company Limited
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Grifols S.A.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Bharat Serums and Vaccines Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Terumo BCT Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們